BACKGROUND
Pertussis (whooping cough) continues to be a public health concern around the world because of increasing morbidity among vaccinated children and adults, severe disease forms in infants and late diagnosis. The actual prevalence of pertussis among children, adolescents and adults is not known, because pertussis is often not only undiag nosed but also is not suspected (1) . Until recently, many considered whooping cough to be an infectious disease only affecting children and not affecting vaccinated children, adolescents or adults (2) . However, pertussis -an acute highly contagious air-borne disease -can affect at any age. Classical pertussis disease is characterized by three stages: catarrhal, paroxysmal and convalescent. Pa roxysms of coughing are often accompanied by vomiting (throwing up), a "whoop" sound, apnea and cyanosis (3, 4) .
The clinical presentation of pertussis depends not only on the patient's age but also on the pertussis vaccination status. The use of pertussis whole-cell vaccines in infants and toddlers has led to decreased circulation of the bacterium in the child po pulation and a marked decrease in the inci dence of the disease. However, vaccine does not result in life-long immunity; indeed, the circulation of the bacterium has not been controlled in the adult population (5) . Adults and adolescents are the main reservoir for B. pertussis today and pertussis remains an endemic disease worldwide despite the availability of comprehensive immunization programmes that primarily target the pediatric population. There are many reasons for this, including incomplete immunity following natural infection, as well as immunization and waning immunity over time.
CASE PRESENTATION
A baby girl was born prematurely at 36 weeks' gestation by spontaneous vaginal delivery. She was her parents' second child. She received two vaccines, BCG and hepatitis B, at birth. She was completely breastfed and was doing well. Her illness started at 7 weeks of age with a dry cough and mild coryzal symptoms. She had no fever. On day three her cough worsened, mostly at night. On day eight of her illness a paroxysmal cough started and she was admitted to the Children's Hos pital with a suspected lower respiratory tract infection. On clinical examination T was 37.4 °C with a respiratory rate of 54-60 breaths per minute. She had mild coryzal symptoms and a nonpro ductive cough. On auscultation the chest was clear with good air entry bilaterally. Heart sounds were normal; heart rate was 132 beats per minute. On day eleven of her illness a whooping cough followed by vomiting started. Apnea started on day twelve of her illness. The girl was transferred to the Pediatric Intensive Care Unit (PICU) on day thirteen because of 9 episodes of post-tussive vomiting and 10 episodes of apnea. She required intubation and ventilation. On day fifteen of her illness, she was extubated. On the same day she developed bradycardia (50-60 beats/min). She had a lumbar puncture, which appeared normal. On day sixteen she was intubated again because of episo des of apnea, cyanosis and vomiting occurring every 30 minutes. Her O 2 saturation decreased to 40%. On day seventeen of her illness she was extubated. She was treated in PICU for a total of 9 days. On days 18-27 of the illness the cough improved and the apnea episodes became less frequent. Chest x-ray showed peribronchial cuffing on day eight and segmental infiltration of the right upper lobe on day fourteen. During her stay in PICU an electrocardiogram, electroencephalogram and head computed tomography were performed, with no significant fin dings. The full blood count showed lymphocytic leukocytosis (Table 1) .
On the second day of the admission (10th day of illness) she was suspected of having pertussis. Blood was taken for investigation of specific B. pertus sis IgM and IgA antibodies on the 10th, 18th and 47th days of the illness ( Table 2 ).
At that time we had no opportunities to perform the pertussis polymerase chain reaction (PCR). Only a third serological blood test detected per tussis IgM antibodies. On the 10th day of the illness she was investigated for Chlamydia pneumoniae and Mycoplasma pneumoniae -specific IgM, IgA, and IgG antibodies. This was because her mother was coughing and was suspected having bron chitis caused by atypical infection. Antibodies were not found. Serological tests were performed by an en zyme-linked immunosorbent assay (ELISA) and estimated according to the manufacturer's ins tructions (Labsystems, Finland). Secretions from the trachea were taken on the 16th day of the illness and when tested by the Ligase chain reaction were negative for C. trachomatis DNA. The patient received amoxicillin for 5 days at home and the first 3 days in the hospital and was later commenced on clarithromycin for 7 days. On the 28th day of her illness the baby was discharged home. The community pediatrician saw her 19 days after discharge. She was well and settled with less frequent cough, no apnea episodes, and normal physical and neurodevelopmental exa minations.
Her 30-year-old mother felt ill one day before her daughter's illness started. She developed a dry cough and several days later she vomited twice while coughing due to thick mucus in her airways. The general practitioner suspected bronchitis caused by atypical infection. A throat swab was taken and tested for C. pneumoniae and M. pneumoniae antigens by direct immunofluorescence. C. pneumoniae antigen was found and she was started on amoxicillin on day four and was subsequently switched to azithromycin. She continued to cough, though on day 20 the cough became less significant, occurring mostly at night. She had not been ill with pertussis previously. We did not have any data about her pertussis vaccination. On day 11 she was tested for C. pneumoniae IgM, IgA and IgG antibodies. C. pneumoniae IgG antibodies were positive. On day 19 she was found to be positive for B. pertussis IgM and IgA antibodies.
Epidemiology history. The infant's family at home consisted of her parents and a 9-year-old sis ter. Her 52-year-old maternal grandmother, who lived alone, was the first family member who started to cough. She had been visiting her granddaughters episodically. The grandmother started to cough 22 days before the infant's illness began. The grandmother's cough lasted for five weeks altogether. Pertussis was not suspected and no in vestigations were performed to determine the aetio logy of her cough. The infant's 9-year-old sister started to cough 14 days after her grandmother. It was a non-productive medium-intensity cough last ing for three weeks. She had received 4 doses of whole-cell vaccine by 2 years of age. As pertussis was not suspected, no tests were performed to explain the cause of her cough. The mother has started to cough after 7 days, and the younger dau ghter after 8 days since the older daughter has started to cough. The father did not have any cough over the whole 3-month-period.
DISCUSSION
Despite successful infant vaccination programmes, pertussis remains endemic in many countries. Wan ing immunity leaves adolescents and adults susceptible to disease and creates potential reservoirs of infection, allowing transmission to vulne rable infants (6) . A reported study from Poland revealed protective immunity against pertussis in 70% of six-year-olds, 68% of seven-year-olds, and only 45% of eight-year-olds (7). Many studies have reported the importance of household and school contacts for pertussis infection. According to the literature (8) in up to 83% of paediatric pertussis cases, the source of pertussis was a close contact at home. As described in our case, it can be assumed that for the baby and mother the source of pertussis was the maternal grandmother and / or the older fully vaccinated sibling in the household. Specific antibodies obtained from the mo ther through the placenta during pregnancy protect a newborn for only a month (9). Shakib et al. (10) investigated pertussis antibodies in postpartum women and their newborns, and their study showed that approximately 75% of infants were born with pertussis antibody levels lower than the modest levels associated with potential protection. Despite effective antibody transfer, nearly 90% of infants were predicted to have little antibody by 6 weeks. As our clinical case showed, the infant's mother did not have protective immunity, and she also became ill with pertussis. The clinical course of B. pertussis infection in our infant was severe, although the mother's was mild. The infant's apnea episodes started on day 12 of the illness and were recurrent. She required intubation and ventilation and stayed in PICU for 9 days. The study from New Zealand comparing 1992 with 2003 shows us that infants are now being treated in PICU more often (11) . Out of 72 children treated in PICU with pertussis, 97% were younger than 12 months old and 81% were less than 3 months old. 35 (49%) received assisted ventilation. Four of them died. 19% were readmitted to PICU. Crowcroft et al. (12) investigated 126 infants <5 months old admitted to London PICU's with respiratory failure, apnea and / or bradycardia, or acute life threatening episodes. Pertussis was diagnosed in 25 (19.8%). Pertussis was clinically suspected on admission in 28% of patients. Two infants died. Only 6 (4%) out of 126 infants had a positive B. pertussis culture. Compared to infants without pertussis, the infants with pertussis had been coughing for longer, had apneas and whooping more often, and had a higher lymphocyte count. In conclusion, it is stated that severe pertussis is under-diagnosed. In a large multicentre surveillance study in Germany, apnea or cyanosis occurred in 16% and complications in 24% of infants younger than six months of age (13) . Most deaths from pertussis occur in infants younger than six months of age (14) . In a casecontrol study designed to identify predictors of deaths in cases of fatal pertussis, 15 of 16 fatalities occurred in infants <2 months of age (15) . Infants intubated for pneumonia were more likely to die than those intubated for apnea. Leukocytosis and pneumonia on initial presentation were predic tors of poor outcome. A clinical case of pertussis for endemic or sporadic cases is defined as an acute cough illness lasting at least 14 days, accompanied by at least one of the following: paroxysms of coughing, inspiratory whoop or post-tussive vomiting (16) . Pertussis should be suspected in any infant death associated with marked leukocytosis, bronchopneumonia or refractory pulmonary hy per tension, particularly in children aged <4 months (17) . Pertussis should be differentiated from respiratory tract infections caused by M. pneu mo niae, Chla my diae spp., respiratory viral in fec tions and tu berculosis. The mainstays are epi de miological data, la boratory investigations. La bo ratory diagnosis of pertussis can be confirmed in 3 ways: isola tion from nasopharyngeal secre tion (bac teriological me thod) is a highly specific but little sen sitive me thod as the use of antibiotics reduces sen sitivity and the specimen collection is too late in the illness. B. pertussis DNA detection test using PCR is more sensitive than the bacteriological method. Serologic tests detecting B. pertussis-specific antibodies by ELISA, using highly purified anti gens, may be useful. Therefore, if for the confirmation of the diagnosis is not possible to perform PCR, it is appropriate to determine specific antibodies in dynamics.
In the case we described above, pertussis was sus pected because of clinical symptoms and signs (a dry cough of increasing severity which later be came paroxysmal, associated with vomiting, whoop ing, apnea episodes and cyanosis), epidemiologi cal data (household contacts -prolonged cough in her grandmother and sister), and the full blood count (FBC) result (lymphocytic leukocytosis). B. per tussis infection was confirmed by laboratory tests when B. pertussis IgM antibodies were detected in the serum (seroconversion). Bronchitis caused by atypical bacteria was suspected in the mother of our patient. The diagnosis of B. pertussis infection in the mother was confirmed on day 19 of her illness by the detection of B. pertussis IgM and IgA antibodies in serum. The diagnosis was also confirmed epidemiologically. The investigations per formed on the mother and the infant enabled us to exclude atypical infection and confirmed B. pertussis infection.
Vaccination is a major pre ventive measure against B. pertussis infection. Pae diatric immunization programmes vary from country to country, but many of them start with a pertussis com ponent contained in vaccine doses received du ring the first year of life, followed by booster doses during the second year of life and before starting school. In order to establish better pertussis control worldwide, the Global Pertussis Initiative Team suggested an extensive advanced vaccine strategy. They proposed the establishment of a global vaccination strategy for adolescents and adults, pregnant women and families (a "cocoon" strategy), and also health workers and childcare workers, using Tdap vaccine (18) . The "cocoon" stra tegy is intended to protect newborns and infants from whooping cough.
CONCLUSIONS
Whooping cough can affect people of all ages. Our presented clinical case of B. pertussis infection to the infant and her mother illustrates the complex diagnostic difficulties in diagnosing pertussis, requiring laboratory confirmation, analysis of epide miological data and appropriate evaluation. Pertussis to the infant and the mother occurred with the typical three stages: catarrhal, paroxysmal and convalescent. The infant underwent a severe form of the disease, but the outcome was good.
